News
Sacituzumab govitecan effective in Black mTNBC patients
Black women may have outcomes comparable to those of other women when given sacituzumab govitecan for the treatment of metastatic TNBC, suggests...
News
PD-L1 cutoff for pembrolizumab in mTNBC confirmed
PD-L1 CPS of at least 10 improves overall survival by 28%-29%. Further analysis of responses to pembrolizumab plus chemotherapy in metastatic TNBC...
News
Pembrolizumab improves event-free survival in early TNBC
Neoadjuvant pembrolizumab benefits early TNBC patients regardless of disease stage and nodal status. Event-free survival improved by about 35%...
News
Genomic instability varies between breast cancer subtypes
Personalized medicine could be a step closer with the discovery that TNBC and ER+ breast cancers should have different genomic instability...
News
Does vitamin D benefit only those who are deficient?
The results will “allow clinicians to better weigh the potential benefits of supplementation against its risk,” such as financial cost.
News
Surgery offers best chance in cancer but needs more ‘support’
“High-quality surgery remains the best chance to cure solid cancer when diagnosed early.”
News
Antiepileptic medications linked to increased priapism risk
If clinicians encounter such cases of priapism, they should be “reported to the regulatory authorities,” said lead researcher Dr. Ana Pejcic.
News
Art therapy linked to slowed Parkinson’s progression
The positive effect of art therapy could be related to “activating the brain’s reward neural network,” said Dr. Iryna Khubetova.
News
‘Impressive’ results for novel antidepressant, so why the FDA delay?
Results showed the drug had a clinical response rate of 80% and a remission rate of almost 70%.
News
Lower thyroid hormone levels a red flag for elevated suicide risk?
Patients with suicidal ideation were 54% less likely to have higher TSH levels.
News
Steroid a promising short-term treatment option for major depression?
“These data continue to support the development of zuranolone as a potential 14-day short course treatment” for MDD episodes, said Dr. Colville...
News
Constipation med boosts cognitive performance in mental illness
“Our study provides exciting early evidence in humans of a new approach that might be a helpful way to treat these residual cognitive symptoms.”...
News
Nivo/ipi combo now ‘standard of care’ in mesothelioma
After 3 years, 23% of patients who received combination immunotherapy were still alive, in comparison with 15% of patients in the chemotherapy arm...
News
Adjuvant pembro success in early melanoma raises questions
“How come all get treated? What about the risks of toxicity? The costs? And where do we fit these patients into clinic?”